International nonproprietary name



Innovative thrombolytic for the treatment of acute myocardial infarction.


This thrombolytic is recommended for worldwide use with a single bolus injection (in 5-10 seconds), which allows immediate medical care to be provided to patients with acute myocardial infarction at the earliest possible time as part of emergency medical care. Currently, tenecteplase is one of the most extensively studied thrombolytic medicines.

Produced by Petrovax Pharm in cooperation with Boehringer Ingelheim.

Product form

Lyophilisate for preparation of solution for intravenous administration (in a kit with solvent sterilised water for injections)
Instruction (PDF)